Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter

Gene Therapy

Volumn 3, Issue 1, 1996, Pages 49-58

  Imler, J L ^a,c   Dupuit, F ^b   Chartier, C ^a   Accart, N ^a   Dieterle A ^a   Schultz, H ^a   Puchelle, E ^b   Pavirani, A ^a  

^a TRANSGENE S A   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

adenovirus; CFTR; gene therapy; lacZ; targeting

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

3T3 CELLS; ADENOVIRUSES, HUMAN; ANIMALS; BASE SEQUENCE; BETA-GALACTOSIDASE; CACO-2 CELLS; CELL LINE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA PRIMERS; FEMALE; GENE EXPRESSION; GENETIC VECTORS; HELA CELLS; HUMANS; LAC OPERON; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RESPIRATORY SYSTEM; TUMOR CELLS, CULTURED;

EID: 0029864727     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Graham FL, Prevec L. Adenovirus-based expression vectors and recombinant vaccines. In: Ellis RW (ed). Vaccines. New Approaches to Immunological Problems. Butterworth-Heinemann: Stoneham, 1992, pp 363-390.
2. Trapnell BC. Adenoviral vectors for gene transfer. Adv Drug Deliv Rev 1993; 12: 185-199.
3. Stratford-Perricaudet LD, Perricaudet M. Gene therapy: the advent of adenovirus. In: JA Wolff (ed). Methods and Applications of Direct Gene Transfer. Birkhäuser: Boston, 1994, pp 344-362.
4. Imler JL. Adenovirus vectors as recombinant viral vaccines. Vaccine 1995; 13: 1143-1151.
5. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ (ed). Methods of Molecular Biology. Vol. 7. Humana Press: Clifton NJ, 1991, pp 109-128.
6. Russell S, Hawkins RE, Winter G. Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res 1993; 21: 1081-1085.
7. Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 1994; 266: 1373-1376.
8. Barinaga M. Step taken toward improved vectors for gene transfer. Science 1994; 266: 1326.
9. Huber BE, Richards CA, Krenitsky TA. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci USA 1991; 88: 8039-8043.
10. Vile RG, Hart IR. In vitro and in vivo targeting of gene expression to melanoma cells. Cancer Res 1993; 53: 962-967
11. Yoshimura K et al. The cystic fibrosis gene has a 'housekeeping'-type promoter and is expressed at low levels in cells of epithelial origin. J Biol Chem 1991; 266: 9140-9144.
12. Yoshimura K et al. Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin. Nucleic Acids Res 1991, 19: 5417-5423.
13. Riordan JR et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
14. - channels in heart. Circ Res 1992; 71: 1002-1007.
15. Mulberg AE et al. Cystic fibrosis transmembrane conductance regulator protein expression in brain. Mem Cell Biophys Biochem 1994; 5: 1684-1688.
16. Trezise AEO et al. Expression of the cystic fibrosis gene in human foetal tissues. Hum Mol Genet 1993; 2: 213-218.
17. Tizzano EF et al. Regional expression of CFTR in developing human respiratory tissues. Am J Respir Cell Mol Biol 1994; 10: 355-362.
18. Rochwerger L, Buchwald M. Stimulation of the cystic fibrosis transmembrane regulator expression by estrogen in vivo. Endocrinology 1993; 133: 921-930.
19. Trezise AEO et al. CFTR expression is regulated during both the cycle of the seminiferous epithelium and the oestrous cycle of rodents. Nat Genet 1993; 3: 157-164.
20. Trapnell BC et al. Down-regulation of cystic fibrosis gene mRNA transcript levels and induction of the cystic fibrosis chloride secretory phenotype in epithelial cells by phorbol ester. J Biol Chem 1991; 266: 10319-10323.
21. Breuer W et al. Protein kinase C mediates down-regulation of cystic fibrosis transmembrane conductance regulator levels in epithelial cells. J Biol Chem 1993; 268. 13935-13939.
22. Breuer W, Kartner N, Riordan JR, Cabantchik ZI. Induction of expression of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 1992; 267: 10465-10469.
23. Bargon J et al. Down-regulation of cystic fibrosis transmembrane conductance regulator gene expression by agents that modulate intracellular divalent cations. Mol Cell Biol 1992; 12: 1872-1878.
24. Nakamura H et al Tumor necrosis factor modulation of expression of the cystic fibrosis transmembrane conductance regulator gene. FEBS Lett 1992; 314: 366-370.
25. Trapnell BC et al. Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc Natl Acad Sci USA 1991; 88: 6565-6569.
26. Puchelle E et al. Differential localization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis airway epithelium. Am J Respir Cell Mol Biol 1992; 7: 485-491.
27. Engelhardt JF et al. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet 1992; 2: 240-248.
28. Engelhardt JF et al Expression of the cystic fibrosis gene in adult human lung. J Clin Invest 1994; 93: 737-749.
29. Jacquot J et al. Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands. Eur Respir J 1993; 6: 169-176.
30. Brezillon S et al. Decreased expression of the CFTR protein in remodeled human nasal epithelium from non-cystic fibrosis patients. Lab Invest 1995; 72: 191-200.
31. Imler J-L et al. An efficient procedure to select and recover recombinant adenovirus vectors. Gene Therapy 1995; 2: 263-268.
32. Chou J-L, Rozmahel R, Tsui L-C. Characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene. J Biol Chem 1991; 266: 24471-24476.
33. Koh J, Sferra TJ, Collins FS. Characterization of the cystic fibrosis transmembrane conductance regulator promoter region. Chromatin context and tissue-specificity. J Biol Chem 1993; 268: 15912-15921.
34. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992; 90: 626-630.
35. Stutts MJ et al. Functional consequences of heterologous expression of the cystic fibrosis transmembrane conductance regulator in fibroblasts. J Biol Chem 1993; 268: 20653-20658.
36. Finkbeiner WE, Carrier SD, Teresi CE. Reverse transcription-polymerase chain reaction (RT-PCR) phenotypic analysis of cell cultures of human tracheal epithelium, tracheobronchial glands, and lung carcinomas. Am J Respir Cell Mol Biol 1993; 9: 547-556.
37. Zeitlin PL et al. CFTR protein expression in primary and cultured epithelia. Proc Natl Acad Sci USA 1992; 89: 344-347.
38. Dupuit F et al. Adenovirus-mediated gene transfer to human surface airway epithelial cells in culture. Am J Respir Crit Care Med 1994; 149: A34.
39. Whitsett JA et al. Human cystic fibrosis transmembrane conductance regulator directed to respiratory epithelial cells of transgenic mice. Nat Genet 1992; 2: 13-20.
40. Dupuit F et al. Regenerating cells in human airway surface epithelium represent preferential targets for recombinant adenovirus. Hum Gene Ther 1995; 6: 1185-1195.
41. Babiss LE, Friedman JM, Darnell JE. Cellular promoters incorporated into the adenovirus genome: effects of viral regulatory elements on transcription rates and cell specificity of albumin and β-globin promoters. Mol Cell Biol 1986; 6. 3798-3806.
42. Quantin B, Perricaudet LD, Tajbakhsh S, Mandel J-L. Adenovirus as an expression vector in muscle cells in vivo Proc Natl Acad Sci USA 1992; 89: 2581-2584.
43. Rosenfeld MA et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143-155.
44. Bout A et al. In vivo adenovirus-mediated transfer of human CFTR cDNA to Rhesus monkey airway epithelium: efficacy, toxicity and safety Gene Therapy 1994; 1: 385-394.
45. Gräble M, Hearing P. Cis and trans requirements of the selective packaging of adenovirus type 5 DNA. J Virol 1992; 66: 723-731.
46. Imler J-L et al. Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of co-dissemination of wild-type and recombinant adenoviruses. Hum Gene Ther 1995; 6: 711-721.
47. Sambrook J, Fritsch EF, Maniatis T. In: Molecular Cloning. A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989.
48. Bonnerot C et al. A β-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc Natl Acad Sci USA 1987; 84: 6795-6799.
49. Kieny MP, Lathe R, Lecocq JP. New versatile cloning and sequencing vectors based on bacteriophage M13. Gene 1983; 26: 91-99.
50. Tournier J-M et al. Culture and characterization of human tracheal gland cells. Am Rev Respir Dis 1990; 141: 1280-1288.
51. Chevillard M et al. Differentiation of human surface upper airway epithelial cells in primary culture on a floating collagen gel. Epith Cell Biol 1993; 2: 17-25.
52. Chevillard M et al. Proliferation, differentiation and ciliary beating of human respiratory ciliated cells in primary culture. Cell Tissue Res 1991; 264: 49-55.